387 related articles for article (PubMed ID: 15542394)
1. Determination of oligosaccharides and glycolipids in amniotic fluid by electrospray ionisation tandem mass spectrometry: in utero indicators of lysosomal storage diseases.
Ramsay SL; Maire I; Bindloss C; Fuller M; Whitfield PD; Piraud M; Hopwood JJ; Meikle PJ
Mol Genet Metab; 2004 Nov; 83(3):231-8. PubMed ID: 15542394
[TBL] [Abstract][Full Text] [Related]
2. Newborn screening for lysosomal storage disorders: clinical evaluation of a two-tier strategy.
Meikle PJ; Ranieri E; Simonsen H; Rozaklis T; Ramsay SL; Whitfield PD; Fuller M; Christensen E; Skovby F; Hopwood JJ
Pediatrics; 2004 Oct; 114(4):909-16. PubMed ID: 15466084
[TBL] [Abstract][Full Text] [Related]
3. Lysosomal storage diseases in non-immune hydrops fetalis pregnancies.
Kooper AJ; Janssens PM; de Groot AN; Liebrand-van Sambeek ML; van den Berg CJ; Tan-Sindhunata GB; van den Berg PP; Bijlsma EK; Smits AP; Wevers RA
Clin Chim Acta; 2006 Sep; 371(1-2):176-82. PubMed ID: 16674934
[TBL] [Abstract][Full Text] [Related]
4. Development of a new tandem mass spectrometry method for urine and amniotic fluid screening of oligosaccharidoses.
Piraud M; Pettazzoni M; Menegaut L; Caillaud C; Nadjar Y; Vianey-Saban C; Froissart R
Rapid Commun Mass Spectrom; 2017 Jun; 31(11):951-963. PubMed ID: 28370531
[TBL] [Abstract][Full Text] [Related]
5. Lysosomal storage diseases presenting as transient or persistent hydrops fetalis.
Bonduelle M; Lissens W; Goossens A; De Catte L; Foulon W; Denis R; Jauniaux E; Liebaers I
Genet Couns; 1991; 2(4):227-32. PubMed ID: 1799421
[TBL] [Abstract][Full Text] [Related]
6. Mass spectrometry in the study of lysosomal storage disorders.
Meikle PJ; Fuller M; Hopwood JJ
Cell Mol Biol (Noisy-le-grand); 2003 Jul; 49(5):769-77. PubMed ID: 14528914
[TBL] [Abstract][Full Text] [Related]
7. Electron microscopy of chorionic villus samples for prenatal diagnosis of lysosomal storage disorders.
Fowler DJ; Anderson G; Vellodi A; Malone M; Sebire NJ
Ultrastruct Pathol; 2007; 31(1):15-21. PubMed ID: 17455094
[TBL] [Abstract][Full Text] [Related]
8. Hydrops fetalis: lysosomal storage disorders in extremis.
Stone DL; Sidransky E
Adv Pediatr; 1999; 46():409-40. PubMed ID: 10645471
[TBL] [Abstract][Full Text] [Related]
9. [Thin-layer chromatography of urine oligosaccharides in diagnosis of some lysosomal storage disorders].
Lugowska A; Tylki-Szymańska A; Sawnor-Korszyńska D
Pediatr Pol; 1995 Oct; 70(10):847-55. PubMed ID: 8649932
[TBL] [Abstract][Full Text] [Related]
10. [Prenatal diagnosis of lysosomal enzymopathies in the Czech Republic].
Poupetová H; Ledvinová J; Chudoba D; Hrebícek M; Kozich V; Macek M; Elleder M
Cas Lek Cesk; 2000 Aug; 139(15):468-74. PubMed ID: 22666927
[TBL] [Abstract][Full Text] [Related]
11. [Hydrops fetalis as an indication for a systematic investigation into the presence of lysosomal storage diseases].
Janssens PM; de Groot AN; de Jong JG; Liebrand-van Sambeek ML; Smits A; Wevers RA
Ned Tijdschr Geneeskd; 2004 Feb; 148(6):264-8. PubMed ID: 15004952
[TBL] [Abstract][Full Text] [Related]
12. Correlation among genotype, phenotype, and biochemical markers in Gaucher disease: implications for the prediction of disease severity.
Whitfield PD; Nelson P; Sharp PC; Bindloss CA; Dean C; Ravenscroft EM; Fong BA; Fietz MJ; Hopwood JJ; Meikle PJ
Mol Genet Metab; 2002 Jan; 75(1):46-55. PubMed ID: 11825063
[TBL] [Abstract][Full Text] [Related]
13. Lysosomal storage disorders in Thailand: the Siriraj experience.
Wasant P; Wattanaweeradej S; Raksadawan N; Kolodny EH
Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():54-8. PubMed ID: 8629143
[TBL] [Abstract][Full Text] [Related]
14. [Fetal ascites as a manifestation of infantile sialidosis. Significance of a study of oligosaccharides in amniotic fluid].
Guibaud P; Cottin X; Maire I; Boyer S; Guibaud S; Coicaud C; Bellon-Azzouzi C; Duvernois JP
J Genet Hum; 1985 Sep; 33(3-4):317-24. PubMed ID: 2414397
[TBL] [Abstract][Full Text] [Related]
15. Prenatal diagnosis of methylmalonic aciduria by analysis of organic acids and total homocysteine in amniotic fluid.
Zhang Y; Yang YL; Hasegawa Y; Yamaguchi S; Shi CY; Song JQ; Sayami S; Liu P; Yan R; Dong JH; Qin J
Chin Med J (Engl); 2008 Feb; 121(3):216-9. PubMed ID: 18298912
[TBL] [Abstract][Full Text] [Related]
16. Amniotic fluid for screening of lysosomal storage diseases presenting in utero (mainly as non-immune hydrops fetalis).
Piraud M; Froissart R; Mandon G; Bernard A; Maire I
Clin Chim Acta; 1996 Apr; 248(2):143-55. PubMed ID: 8740579
[TBL] [Abstract][Full Text] [Related]
17. Prenatal diagnosis of free sialic acid storage disorders (SASD).
Aula N; Aula P
Prenat Diagn; 2006 Aug; 26(8):655-8. PubMed ID: 16715535
[TBL] [Abstract][Full Text] [Related]
18. Newborn screening for lysosomal storage disorders.
Meikle PJ; Ranieri E; Ravenscroft EM; Hua CT; Brooks DA; Hopwood JJ
Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():104-10. PubMed ID: 11400743
[TBL] [Abstract][Full Text] [Related]
19. A case of tyrosinaemia type I with normal level of succinylacetone in the amniotic fluid.
Grenier A; Cederbaum S; Laberge C; Gagné R; Jakobs C; Tanguay RM
Prenat Diagn; 1996 Mar; 16(3):239-42. PubMed ID: 8710777
[TBL] [Abstract][Full Text] [Related]
20. Rapid prenatal testing for human beta-glucuronidase deficiency (MPS VII).
Natowicz MR; Isman F; Prence EM; Cedrone P; Allen JJ
Genet Test; 2003; 7(3):241-3. PubMed ID: 14642000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
